WHO WE ARE

ZIM is an innovative drug delivery solution provider focusing on improving patient convenience and adherence to drug intake.

We offer a range of technology based drug delivery solutions and non-infringing proprietary manufacturing processes for production and supply of innovative and differentiated generic pharmaceutical products to our customers globally.

WHAT WE DO

ZIM provides its customers with a comprehensive range of value added solid dosage differentiated generic products in semi-finished and finished categories / formulations. These include granules, pellets (sustained, modified, extended release), taste masked powders, suspensions, tablets, capsules and its recently developed Oral Thin Films (OTF).

How We Help You

ZIM uses its proprietary knowledge, technology and manufacturing process expertise to bridge the technology gap in Tier III Pharmerging and ROW markets while assisting local players in various geographies to launch differentiated / combination generic products to compete in their respective local markets.

Latest News

The Financial World: ZIM Laboratories Limited Listing on BSE Main Board

ZIM Laboratories Limited (ZIM) has been listed on the BSE Main Board on June 8, 2018. The book value price of ZIM was Rs 160 per equity share. Anwar Daud, Chairman & Managing Director, told mediapersons here recently that ZIM is amongst the few global companies to have developed and commercialized the oral film technology,…

June 13, 2018 | 09:00 PM

APN News: ZIM Laboratories Limited to List on BSE Main Board on June 8, 2018

ZIM Laboratories Limited (ZIM) – is a unique R&D centered pharmaceutical company focused on developing and supply of complex generics products based on proprietary Novel Drug Delivery Solutions (NDDS). Promoted by Technocrat Dr. Anwar Daud, the company has a Unique R&D focused business model helping customers with product development, co-development, out licensing, manufacturing, supplies and…

June 11, 2018 | 09:00 PM

Global Prime News: ZIM Laboratories Limited to List on BSE Main Board on June 8, 2018

ZIM is amongst a few companies globally to have developed and commercialized the oral film technology. The first Indian company to manufacture multi-layer thin films – that contain more than one API on a single thin strip. Company to get listed on BSE Mainboard on June 08, 2018. The book value price of ZIM is…

June 11, 2018 | 09:00 PM